Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis
Journal of Reports in Pharmaceutical Sciences · 06.10.2024 · 12 (1)
DOI: 10.5812/jrps-151774 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Reports in Pharmaceutical Sciences, online erschienen am 06.10.2024. Verfasst von Alireza Sheikhi und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Brachyury has recently garnered attention as both a biomarker and a causative factor in chordoma development, making it a promising therapeutic target.
Objectives
Herein, we report a systematic review and meta-analysis to evaluate brachyury as a diagnostic biomarker and therapeutic molecular target in chordomas.
Methods
Scopus, PubMed/Medline, Cochrane Library databases, and Web of Science were searched up to July 18, 2024, without any restrictions. The Comprehensive Meta-Analysis version 3.0 software was used to calculate the event rate (ER) with a 95% confidence interval (CI). We utilized STRING to explore functional interactions among the studied genes.
Results
Twenty-five studies related to the expression of brachyury and five related to the treatment vaccine of brachyury were included in this category. The ER of brachyury expression among chordoma patients was 92.2% (95% CI: 87.3% - 95.3%), with I² = 74.65%. Among the five studies related to treatment vaccines, there were three studies with Phase 1, one with Phase 2, and a case report.
Conclusions
The high expression suggests that brachyury serves as a reliable diagnostic marker for chordomas. The findings indicate potential therapeutic implications for targeting brachyury in chordoma treatment.
Zitieren
APA
Sheikhi, A., Golchin, N., & Sadeghi, M. (2024). Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis. Journal of Reports in Pharmaceutical Sciences, 12(1). https://doi.org/10.5812/jrps-151774
Vancouver
Sheikhi A, Golchin N, Sadeghi M. Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis. Journal of Reports in Pharmaceutical Sciences. 2024;12(1). doi:10.5812/jrps-151774
BibTeX
@article{Sheikhi2024,
author = {Sheikhi, Alireza and Golchin, Navid and Sadeghi, Masoud},
title = {Brachyury as a Diagnostic Biomarker and Therapeutic Molecular Target in Chordomas: A Systematic Review, Meta-Analysis, and Bioinformatics Analysis},
journal = {Journal of Reports in Pharmaceutical Sciences},
year = {2024},
volume = {12},
number = {1},
doi = {10.5812/jrps-151774}
}
EUVIMED